EP 1059926 A2 20001220 - PROSTAGLANDIN E 2?/F 2$g(a)? COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL
Title (en)
PROSTAGLANDIN E 2?/F 2$g(a)? COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL
Title (de)
KOMBINATION, BESTEHEND AUS DEN PROSTAGLANDINEN E2/F2-ALPHA, ZUR BEHANDLUNG DER IMPOTENZ UND ZUR ERHÖHUNG DER SEXUELLLEN ERREGBARKEIT
Title (fr)
COMBINAISON DE PROSTAGLANDINES E 2?/F 2$g(a)?, DESTINEE AU TRAITEMENT DE L'IMPUISSANCE ET A L'ACCROISSEMENT DE L'EXCITATION SEXUELLE
Publication
Application
Priority
- US 9826609 W 19981215
- US 99294697 A 19971218
- US 508798 A 19980109
- US 3837898 A 19980311
Abstract (en)
[origin: WO9930718A2] A method of treating and a composition for treating erectile dysfunction in a male patient or female sexual arousal dysfunction, comprising the step of administering to the patient a unit dose of a formulation comprising an effective amount of a prostaglandin, namely prostaglandin E1, prostaglandin E2, or pharmaceutically acceptable salts or derivatives thereof, wherein the prostaglandin is formulated with a small amount of prostaglandin F alpha 2 together with a pharmaceutically acceptable delivery medium and/or a lubricant. The method also contemplates PGE2 with phentolamine mesylate, with or without PGF2 alpha .
IPC 1-7
IPC 8 full level
A61K 31/557 (2006.01)
CPC (source: EP)
A61K 31/557 (2013.01)
Citation (search report)
See references of WO 9930718A2
Designated contracting state (EPC)
CH DE FR GB LI SE
DOCDB simple family (publication)
WO 9930718 A2 19990624; WO 9930718 A3 19990910; AU 1827299 A 19990705; CA 2314369 A1 19990624; CN 1282249 A 20010131; EP 1059926 A2 20001220
DOCDB simple family (application)
US 9826609 W 19981215; AU 1827299 A 19981215; CA 2314369 A 19981215; CN 98812205 A 19981215; EP 98963194 A 19981215